Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.
about
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study.Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical tri
P2860
Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@en
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@nl
type
label
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@en
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@nl
prefLabel
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@en
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@nl
P2093
P2860
P1433
P1476
Cost effectiveness of darunavi ...... ith HIV-1 infection in Canada.
@en
P2093
Anita J Brogan
Erik Smets
Ines Adriaenssen
Josephine A Mauskopf
Sarah A L Manuel
P2860
P2888
P304
P356
10.1007/S40273-014-0173-7
P577
2014-09-01T00:00:00Z
P5875
P6179
1002540664